AICentralResources
AI Tool Comparison

Comparing as AI Medical Imaging & Diagnostics
Paige vs PathAI

VS
Paige official logo and brand icon

Paige

Enterprise
Visit WebsiteFull Review
PathAI official logo and brand icon

PathAI

Enterprise
Visit WebsiteFull Review

Verdict by Category

Detailed category analysis is not available for this comparison.
View Paige View PathAI
Feature & Spec Matrix

Detailed Comparison23 Criteria

Complete side-by-side breakdown of specifications, capabilities, and feature parity

Swipe horizontally to compare features
Feature / Spec
Paige
Paige
PathAI
PathAI
Pricing Model
EnterpriseAI clinical pathology diagnostics — Institutional and hospital laboratory enterprise licensing
EnterpriseAI pathology solutions for biopharma — Custom enterprise partnership agreements only
Starting Price
Custom / Contact Sales
Custom / Contact Sales
Free Plan & Trial Scope
Difference
No free plan — enterprise hospital and biopharma contracts via sales team
No free plan — enterprise and biopharma contracts only; acquired by Roche in May 2026
User Rating Score
Unrated
Unrated
Ideal Workflow / Use Case
Difference
Cancer centers, hospital pathology labs, and biopharma companies needing FDA-cleared AI for prostate and breast cancer diagnosis, digital pathology viewing, and biomarker research
Hospital pathology labs and biopharma companies needing AI-powered digital pathology for oncology diagnostics, companion diagnostic development, and clinical trial tissue analysis
Enterprise & Scalability
Difference
FDA 510k cleared primary diagnosis AI, CE marked, HIPAA compliant, SOC 2 Type II, CAP/CLIA compatible lab workflows, HL7/FHIR integration, GPU infrastructure with 10+ petaFLOPS AIRI compute, enterprise pathology scanner compatibility (Leica Aperio, Hamamatsu NanoZoomer, Philips IntelliSite), and dedicated implementation support
HIPAA compliant, CAP/CLIA certified lab services, FDA 510k cleared algorithms, SOC 2 Type II, full enterprise LIS/PACS integration, dedicated implementation and scientific support, biopharma research service contracts, and 450+ pathologist annotation network
Core Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Research & Education Tools
FullFocus — FDA 510k-cleared digital pathology image viewer compatible with Leica, Hamamatsu, and Philips scanners
Supported
Supported
Paige Prostate — FDA-cleared AI for prostate cancer detection and Gleason grading
Difference
Paige Advantage
Not listed
Paige Breast — AI-assisted breast cancer detection and analysis on whole slide images
Supported
Supported
First ever FDA clearance for AI in primary pathology diagnosis — historic regulatory milestone
Difference
Paige Advantage
Not listed
First CE mark in AI pathology — cleared for clinical use across EU member states
Difference
Paige Advantage
Not listed
AIRI infrastructure with 10+ petaFLOPS GPU compute for large-scale model training
Difference
Paige Advantage
Not listed
1.2M+ slide digital archive from Memorial Sloan Kettering for model training
Difference
Paige Advantage
Not listed
Biopharma platform for biomarker discovery, companion diagnostics, and drug development
Supported
Supported
Scanner-neutral slide viewer compatible with multiple FDA-cleared scanner systems
Supported
Supported
Spinout from Memorial Sloan Kettering with exclusive access to MSK's pathology IP and 25M+ slides
Difference
Paige Advantage
Not listed
20+ FDA-cleared and research-grade AI algorithms for oncology and liver disease
Difference
Not listed
PathAI Advantage
32.5M+ expert pathologist annotations — one of the largest training datasets in pathology AI
Difference
Not listed
PathAI Advantage
PathExplore panel of human interpretable features (HIFs) for tumor microenvironment research
Difference
Not listed
PathAI Advantage
CLIA-certified lab services for biopharma clinical trial tissue analysis
Difference
Not listed
PathAI Advantage
Acquired by Roche in May 2026 — now backed by global diagnostic infrastructure
Difference
Not listed
PathAI Advantage
Partnerships with Moffitt Cancer Center, University Hospital Zurich, Bristol-Myers Squibb, and Merck
Difference
Not listed
PathAI Advantage
Paige icon

Paige Pros & Cons

Pros

  • First FDA clearance for AI in primary pathology diagnosis — a historic regulatory milestone
  • First CE mark for AI pathology in Europe — validated for clinical use across EU
  • Founded on MSK's 25M+ pathology slides — the richest cancer pathology training set in the world
  • AIRI infrastructure with 10+ petaFLOPS — enterprise-grade AI compute at clinical scale
  • FullFocus viewer is scanner-neutral with FDA clearances for Leica, Hamamatsu, and Philips
  • The most credentialed AI pathology company in terms of regulatory approvals
  • Backed by Goldman Sachs, Breyer Capital, and Healthcare Venture Partners

Cons

  • Enterprise and institutional access only — not available to small or independent pathology labs
  • No published pricing — all contracts negotiated through enterprise procurement
  • Requires digital pathology infrastructure — scanners, storage, and LIS integration
  • Pathologist review and sign-off still required for all AI-generated results
  • Focused on pathology and oncology — not a general medical imaging platform
PathAI icon

PathAI Pros & Cons

Pros

  • Acquired by Roche (May 2026) — now backed by the world's largest diagnostics company
  • 32.5M+ expert annotations — one of the world's largest pathology AI training datasets
  • 20+ AI algorithms covering oncology, liver disease, and tumor microenvironment analysis
  • AISight is scanner-neutral — works with Leica, Hamamatsu, Philips scanners with FDA clearance
  • CLIA-certified lab services for biopharma clinical trial support
  • Partnerships with BMS, Merck, Moffitt Cancer Center, and University Hospital Zurich
  • First AI pathology company recognized as a leader in CB Insights Digital Pathology market map

Cons

  • Acquired by Roche in May 2026 — future product roadmap and independent operations may change
  • Enterprise and biopharma-focused — not accessible to independent pathologists or small labs
  • No self-serve pricing or trial — all engagements are through enterprise procurement
  • Requires digital pathology infrastructure (scanners, storage, LIS integration)
  • Integration complexity for labs not yet on digital pathology workflows
Head-to-Head Battle Cards

Popular Comparisons

Direct feature matrices, pricing breakdowns, and real-world benchmark duels

All AI Healthcare Tools comparisons
PathAI vs Abridge Comparison Battle Card - Features, Pricing & Review in AI Healthcare Tools
Direct head-to-head AI tool comparison between PathAI and Abridge in AI Healthcare Tools featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
AI Healthcare ToolsCompare
Paige vs Suki AI Comparison Battle Card - Features, Pricing & Review in AI Healthcare Tools
Direct head-to-head AI tool comparison between Paige and Suki AI in AI Healthcare Tools featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
AI Healthcare ToolsCompare
Google NotebookLM vs Obsidian Comparison Battle Card - Features, Pricing & Review in AI Research Synthesis & Personal Knowledge Management
Direct head-to-head AI tool comparison between Google NotebookLM and Obsidian in AI Research Synthesis & Personal Knowledge Management featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
AI Research Synthesis & Personal Knowledge ManagementCompare
OpenAI Codex vs ChatGPT Comparison Battle Card - Features, Pricing & Review in OpenAI Developer & Assistant Workflows
Direct head-to-head AI tool comparison between OpenAI Codex and ChatGPT in OpenAI Developer & Assistant Workflows featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
OpenAI Developer & Assistant WorkflowsCompare